Deactivated Cas9 gene editing is a powerful tool for precise genome regulation without inducing DNA breaks. By pairing dCas9 with effector domains, it enables targeted gene activation, repression, or epigenetic modifications. This technology is widely used in cell therapy development, offering a safer and more controlled approach for treating genetic disorders, cancers, and other complex diseases.